BioCryst Pharmaceuticals Inc (BCRX)
4.23
-0.15
(-3.42%)
USD |
NASDAQ |
Apr 24, 16:00
4.23
0.00 (0.00%)
After-Hours: 17:57
BioCryst Pharmaceuticals Cash from Investing (TTM): -131.50M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -131.50M |
| September 30, 2023 | -25.81M |
| June 30, 2023 | -118.47M |
| March 31, 2023 | -196.88M |
| December 31, 2022 | -128.24M |
| September 30, 2022 | -216.57M |
| June 30, 2022 | -139.28M |
| March 31, 2022 | -37.34M |
| December 31, 2021 | 15.80M |
| September 30, 2021 | 48.34M |
| June 30, 2021 | 6.529M |
| March 31, 2021 | -2.907M |
| December 31, 2020 | -6.856M |
| September 30, 2020 | -12.01M |
| June 30, 2020 | 45.57M |
| March 31, 2020 | 72.78M |
| December 31, 2019 | 77.93M |
| September 30, 2019 | 58.51M |
| June 30, 2019 | 25.47M |
| March 31, 2019 | 4.722M |
| December 31, 2018 | 4.768M |
| September 30, 2018 | -49.45M |
| June 30, 2018 | -37.96M |
| March 31, 2018 | -62.85M |
| December 31, 2017 | -64.64M |
| Date | Value |
|---|---|
| September 30, 2017 | -17.08M |
| June 30, 2017 | 2.901M |
| March 31, 2017 | 34.70M |
| December 31, 2016 | 23.27M |
| September 30, 2016 | 30.11M |
| June 30, 2016 | -9.977M |
| March 31, 2016 | -11.35M |
| December 31, 2015 | -18.00M |
| September 30, 2015 | -68.10M |
| June 30, 2015 | -45.10M |
| March 31, 2015 | -42.90M |
| December 31, 2014 | -39.98M |
| September 30, 2014 | 10.85M |
| June 30, 2014 | 0.172M |
| March 31, 2014 | -6.562M |
| December 31, 2013 | -3.467M |
| September 30, 2013 | 2.441M |
| June 30, 2013 | 19.92M |
| March 31, 2013 | 15.42M |
| December 31, 2012 | 24.88M |
| September 30, 2012 | 18.55M |
| June 30, 2012 | 23.21M |
| March 31, 2012 | 15.10M |
| December 31, 2011 | 11.32M |
| September 30, 2011 | 22.13M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-216.57M
Minimum
Sep 2022
77.93M
Maximum
Dec 2019
-35.00M
Average
-6.856M
Median
Dec 2020
Cash from Investing (TTM) Benchmarks
| AIM ImmunoTech Inc | -0.832M |
| Perspective Therapeutics Inc | 24.37M |
| Protalix BioTherapeutics Inc | -16.71M |
| Electromed Inc | -1.219M |
| Armata Pharmaceuticals Inc | -8.134M |